ArticleMultiple sclerosis journal - experimental, translational and clinical

Short-term outcomes of pediatric multiple sclerosis patients treated with alemtuzumab at a Canadian University multiple sclerosis clinic.

David Jure Hunt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.